The bispecific T-cell engager tarlatamab demonstrated favorable antitumor activity in a small cohort with small cell lung ...

McNally was speaking at the Outsourcing in Clinical Trials Europe, in Barcelona on 30 April. She said Parexel has ‘rescued’ ...

Symptoms of inflammatory bowel disease (IBD) range from diarrhea and abdominal pain to nausea, fever, loss of appetite, fatigue and, at times, rectal bleeding. No single test can confirm IBD, which ...

A University of Cincinnati researcher launched an app, called High Enroll, to connect patients to clinical trials. The most common barrier to human subject research is a lack of awareness. Many ...

The answer to this inquiry is “yes” — but maybe “no.” Will confidentiality agreements shield any prior art concerns? Once ...

A Department of Health and Human Services spokesperson called the move "a radical departure from past practices." ...

Wegovy (semaglutide) could offer a new option to treat severe liver disease based on new clinical trial evidence. The GLP-1 ...

The transition from preclinical development to clinical trials is a critical, with approximately 89% of drugs failing. Nearly half of these failures stem from unexpected and unmanageable human ...

Pykus Therapeutics reveals promising results for PYK-2101, a retinal sealant that enhances recovery and improves patient ...

The results offer some of the first glimpses into real-world findings of the Janus kinase inhibitor in patients with ...

LIVEKIDNEY.BIO (LiveKidney), a clinical-stage biotech company developing cell-based therapies for kidney diseases, announced today that it has enrolled its first patient in a Phase I/IIa study of ...